Fennec Pharmaceuticals Inc.
FENC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $22 | $19 | $23 | $27 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $19 | $18 | $15 | $13 |
| Inventory | $2 | $2 | $1 | $1 |
| Other Curr. Assets | $2 | $2 | $3 | $4 |
| Total Curr. Assets | $46 | $41 | $43 | $44 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $2 | $3 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $3 | $1 |
| Total NC Assets | $3 | $4 | $3 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $49 | $45 | $46 | $45 |
| Liabilities | – | – | – | – |
| Payables | $6 | $6 | $5 | $3 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $2 | $3 | $4 |
| Total Curr. Liab. | $10 | $8 | $8 | $7 |
| LT Debt | $18 | $19 | $19 | $19 |
| Deferred Rev, NC | $25 | $25 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $0 | $25 | $25 |
| Total NC Liab. | $44 | $44 | $44 | $44 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $54 | $52 | $52 | $51 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $148 | $146 | $146 | $146 |
| Retained Earnings | -$224 | -$224 | -$221 | -$220 |
| AOCI | $1 | $1 | $1 | $1 |
| Other Equity | $71 | $69 | $68 | $67 |
| Total Equity | -$4 | -$7 | -$6 | -$6 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $49 | $45 | $46 | $45 |
| Net Debt | -$4 | $1 | -$3 | -$7 |